News Release Dated July 17, 2024
Company: Japan System Techniques Co., Ltd.
Representative: Takeaki Hirabayashi, President and CEO
Stock code: 4323, Tokyo Stock Exchange, Prime Market
Contact: Taku Hirabayashi, Director and Senior Officer
Tel: +81-6-4560-1000

Start of COPD Patient Education Joint Programwith the Town of Koryo (Nara Prefecture) and AstraZeneca K.K.
Japan System Techniques Co., Ltd. (“JAST”) has entered into an agreement with Koryo Town (District ofKitakatsuragi, Nara Prefecture) and AstraZeneca K.K. for cooperation concerning education programs forindividuals who have chronic obstructive pulmonary disease (“COPD”). The details are as per attached.
This matter will have only a negligible effect on JAST’s consolidated results. An announcement will be madein a timely manner if there is any additional information that should be disclosed.

Launch the Future

NEWS RELEASE

July 17, 2024
Japan System Techniques Co., Ltd.

Start of COPD Patient Education Joint Programwith the Town of Koryo (Nara Prefecture) and AstraZeneca K.K.
Japan System Techniques Co., Ltd. (“JAST”) has entered into an agreement with Koryo Town (District of Kitakatsuragi, NaraPrefecture) and AstraZeneca K.K. for cooperation concerning education programs for individuals who have chronic
obstructive pulmonary disease (“COPD”).
■ Background of the Joint COPD Education Program
COPD is a group of lung diseases including emphysema, chronic bronchitis and others that over time makes breathing
increasingly difficult. The primary causes are smoking habits over many years and problems involving the growth of the lungs.
In recent years, there has been increasing interest concerning the link between COPD and frailty and sarcopenia. Inflammation
throughout the body can cause a variety of other disorders of the organs in addition to COPD (source: SMART LIFE PROJECT“COPD,” Ministry of Health, Labour and Welfare, https://www.smartlife.mhlw.go.jp/event/disease/copd/, viewed on July 11,2024)
Koryo Town wanted to start programs for the diagnosis and proper treatment of COPD as part of measures to help residents
enjoy a long healthy life. The goal is to prevent this disease from becoming serious. To accomplish this, Koryo town officials
began to examine ways to work with companies for educational programs for advances regarding awareness of COPD andthe diagnosis and treatment of this chronic disease. This process led to the decision to work with AstraZeneca K.K., which
has activities for increasing the proper treatment of COPD in accordance with guidelines with an aim to prevent COPD
symptoms from worsening and to contribute to comprehensive medical care. As such, the company considered an alliancewith JAST. With a view to improve the health and quality of life of Japanese people, JAST is engaged in data analysis
involving national health insurance and health care for people in the later stages of old age, and provide local governments
and the national government with ideas for ways to alter the behavior of people.
AstraZeneca K.K. and JAST support the following objectives of the planned COPD educational activities of Koryo Town andrecognize the medical significance of the town’s plan. Hence, the two companies responded to the request of Koryo town
officials to establish an alliance based on the terms of the contract signed.
(1) Contribute to an increase in suitable COPD treatments and knowledge about these treatments.
(2) For improving the health and quality of life of Japanese people, increase activities for altering the behavior of people basedon the analysis of national health insurance data and data about health care for people in the later stages of old age■ Future Outlook
JAST expects this partnership to become a new approach for national health insurance and health care for people in the laterstages of old age, and the following activities to result in advances involving the awareness, diagnosis and treatment of COPD.
JAST will continue to use educational activities involving diseases and disorders to help people covered by health insurance
to remain in good health.
■ Inquiries
Japan System Techniques Co., Ltd.
Contact: Healthcare Innovation Business Division
TEL: +81-3-6718-2785 (Tokyo), +81-6-4560-1050 (Osaka)E-mail: jmics-sales@jast.co.jp
URL: https://jmics.jp/